These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16329401)

  • 1. [Economic value of tiotropium in the treatment of chronic obstructive pulmonary disease].
    Schramm W; Haake D; Brandt A
    Praxis (Bern 1994); 2005 Nov; 94(46):1803-10. PubMed ID: 16329401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain.
    Rutten-van Mölken MP; Oostenbrink JB; Miravitlles M; Monz BU
    Eur J Health Econ; 2007 Jun; 8(2):123-35. PubMed ID: 17370096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.
    Oostenbrink JB; Rutten-van Mölken MP; Monz BU; FitzGerald JM
    Value Health; 2005; 8(1):32-46. PubMed ID: 15841892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-effectiveness analysis of tiotropium compared to ipratropium and salmeterol].
    García Ruiz AJ; Leiva Fernández F; Martos Crespo F
    Arch Bronconeumol; 2005 May; 41(5):242-8. PubMed ID: 15919004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.
    Dalal AA; Roberts MH; Petersen HV; Blanchette CM; Mapel DW
    Int J Chron Obstruct Pulmon Dis; 2010 Dec; 6():13-22. PubMed ID: 21311689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease.
    Oba Y
    Mayo Clin Proc; 2007 May; 82(5):575-82. PubMed ID: 17493425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of tiotropium and salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) in Greece.
    Maniadakis N; Tzanakis N; Fragoulakis V; Hatzikou M; Siafakas N
    Curr Med Res Opin; 2006 Aug; 22(8):1599-607. PubMed ID: 16870084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial.
    Hoogendoorn M; Al MJ; Beeh KM; Bowles D; Graf von der Schulenburg JM; Lungershausen J; Monz BU; Schmidt H; Vogelmeier C; Rutten-van Mölken MP
    Eur Respir J; 2013 Mar; 41(3):556-64. PubMed ID: 22700844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic analyses comparing tiotropium with ipratropium or salmeterol in UK patients with COPD.
    Gani R; Griffin J; Kelly S; Rutten-van Mölken M
    Prim Care Respir J; 2010 Mar; 19(1):68-74. PubMed ID: 20094687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which long-acting bronchodilator is most cost-effective for the treatment of COPD?
    Hoogendoorn M; Kappelhoff BS; Overbeek JA; Wouters EF; Rutten-van Mölken MP
    Neth J Med; 2012 Oct; 70(8):357-64. PubMed ID: 23065983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using cost-effectiveness analysis to sharpen formulary decision-making: the example of tiotropium at the Veterans Affairs health care system.
    Onukwugha E; Mullins CD; DeLisle S
    Value Health; 2008; 11(5):980-8. PubMed ID: 18194405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the pharmacoeconomic effect of adding tiotropium bromide to the management of chronic obstructive pulmonary disease patients in Singapore.
    Lee KH; Phua J; Lim TK
    Respir Med; 2006 Dec; 100(12):2190-6. PubMed ID: 16635566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease.
    Oostenbrink JB; Rutten-van Mölken MP; Al MJ; Van Noord JA; Vincken W
    Eur Respir J; 2004 Feb; 23(2):241-9. PubMed ID: 14979498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK
    Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and economic outcomes in an observational study of COPD maintenance therapies: multivariable regression versus propensity score matching.
    Roberts MH; Dalal AA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():221-33. PubMed ID: 22500122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM;
    N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD.
    Dalal AA; Petersen H; Simoni-Wastila L; Blanchette CM
    J Med Econ; 2009; 12(4):339-47. PubMed ID: 19827993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
    Drescher GS; Carnathan BJ; Imus S; Colice GL
    Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative health-care cost advantage of ipratropium over tiotropium in COPD patients.
    Dormuth CR; Yamaguchi J; Wilmer B; Hosick D; Stürmer T; Carney G
    Value Health; 2012; 15(2):269-76. PubMed ID: 22433758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.
    Somand H; Remington TL
    Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.